1 – 50 of 92
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial.
(
- Contribution to journal › Article
-
Mark
Risk of male breast cancer in users of testosterone 5a reductase inhibitors
2016) 2016 Annual Meeting of the American Society of Clinical Oncology In Journal of Clinical Oncology 34(Suppl 15).(
- Contribution to journal › Published meeting abstract
- 2015
-
Mark
Ewing Sarcoma: Current Management and Future Approaches Through Collaboration.
(
- Contribution to journal › Scientific review
-
Mark
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation.
(
- Contribution to journal › Article
-
Mark
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial
(
- Contribution to journal › Article
-
Mark
Routine Imaging for Diffuse Large B-Cell Lymphoma in First Complete Remission Does Not Improve Post-Treatment Survival: A Danish-Swedish Population-Based Study.
(
- Contribution to journal › Article
-
Mark
Stable Peptide of the Endogenous Opioid Enkephalin Precursor and Breast Cancer Risk.
(
- Contribution to journal › Article
- 2014
-
Mark
Emergence of New ALK Mutations at Relapse of Neuroblastoma.
(
- Contribution to journal › Article
-
Mark
Musculoskeletal Pain in Patients With Chronic Myeloid Leukemia After Discontinuation of Imatinib: A Tyrosine Kinase Inhibitor Withdrawal Syndrome?
(
- Contribution to journal › Letter
-
Mark
Effect of Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma in Situ: 20 Years Follow-Up in the Randomized SweDCIS Trial.
(
- Contribution to journal › Article
-
Mark
Collection and Use of Family History in Oncology Clinics.
(
- Contribution to journal › Letter
-
Mark
t(14;18) Translocation: A Predictive Blood Biomarker for Follicular Lymphoma
(
- Contribution to journal › Article
-
Mark
Later stage at diagnosis and worse survival in cutaneous malignant melanoma among men living alone: a nationwide population-based study from sweden.
(
- Contribution to journal › Article
-
Mark
Cyclophosphamide Compared With Ifosfamide in Consolidation Treatment of Standard-Risk Ewing Sarcoma: Results of the Randomized Noninferiority Euro-EWING99-R1 Trial.
(
- Contribution to journal › Article
- 2013
-
Mark
Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
(
- Contribution to journal › Article
-
Mark
90Yttrium-Ibritumomab-Tiuxetan as First-Line Treatment for Follicular Lymphoma: 30 Months of Follow-Up Data From an International Multicenter Phase II Clinical Trial.
(
- Contribution to journal › Article
-
Mark
Communication and Trust in the Care Provided to a Dying Parent: A Nationwide Study of Cancer-Bereaved Youths.
2013) In Journal of Clinical Oncology(
- Contribution to journal › Article
-
Mark
International Myeloma Working Group Recommendations for the Treatment of Multiple Myeloma-Related Bone Disease.
(
- Contribution to journal › Article
-
Mark
Benefits and Adverse Events in Younger Versus Older Patients Receiving Neoadjuvant Chemotherapy for Osteosarcoma: Findings From a Meta-Analysis.
(
- Contribution to journal › Article
-
Mark
Randomized, Multicenter, Phase II Study of CO-101 Versus Gemcitabine in Patients With Metastatic Pancreatic Ductal Adenocarcinoma: Including a Prospective Evaluation of the Role of hENT1 in Gemcitabine or CO-101 Sensitivity.
(
- Contribution to journal › Article
-
Mark
Evaluation of Human Papillomavirus Antibodies and Risk of Subsequent Head and Neck Cancer.
(
- Contribution to journal › Article
- 2012
-
Mark
Prostate Cancer Screening: Facts, Statistics, and Interpretation in Response to the US Preventive Services Task Force Review
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Upfront Autologuos Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01.
(
- Contribution to journal › Article
-
Mark
Absolute Risk Prediction of Second Primary Thyroid Cancer Among 5-Year Survivors of Childhood Cancer.
2012) In Journal of Clinical Oncology(
- Contribution to journal › Article
-
Mark
Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study.
(
- Contribution to journal › Article
-
Mark
Is Family History Associated With Improved Survival in Patients With Gastric Cancer?
(
- Contribution to journal › Article
-
Mark
FACT: An Open-Label Randomized Phase III Study of Fulvestrant and Anastrozole in Combination Compared With Anastrozole Alone as First-Line Therapy for Patients With Receptor-Positive Postmenopausal Breast Cancer.
(
- Contribution to journal › Article
-
Mark
Targeting p53 in Vivo: A First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer.
(
- Contribution to journal › Article
-
Mark
Impact of Cigarette Smoking on Cancer Risk in the European Prospective Investigation into Cancer and Nutrition Study.
2012) In Journal of Clinical Oncology(
- Contribution to journal › Article
- 2011
-
Mark
Challenges to the Development of New Agents for Molecularly Defined Patient Subsets: Lessons From BRCA1/2-Associated Breast Cancer
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Management of Seminomatous Testicular Cancer: A Binational Prospective Population-Based Study From the Swedish Norwegian Testicular Cancer Study Group (SWENOTECA).
(
- Contribution to journal › Article
-
Mark
Immunotherapy for Glioblastoma: The Devil Is in the Details Reply
(
- Contribution to journal › Letter
-
Mark
Success Story of Targeted Therapy in Chronic Myeloid Leukemia: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2008.
(
- Contribution to journal › Article
-
Mark
Familial Mortality and Familial Incidence in Cancer.
(
- Contribution to journal › Article
-
Mark
Familial risks in cancer of unknown primary: tracking the primary sites.
(
- Contribution to journal › Article
-
Mark
Population-Based Study of Treatment Guided by Tumor Marker Decline in Patients With Metastatic Nonseminomatous Germ Cell Tumor: A Report From the Swedish-Norwegian Testicular Cancer Group.
(
- Contribution to journal › Article
-
Mark
Response-Guided Induction Therapy in Pediatric Acute Myeloid Leukemia With Excellent Remission Rate.
(
- Contribution to journal › Article
-
Mark
Digoxin use and the risk of breast cancer in women
(
- Contribution to journal › Article
- 2010
-
Mark
Patterns of Improved Survival in Patients With Multiple Myeloma in the Twenty-First Century: A Population-Based Study.
(
- Contribution to journal › Article
-
Mark
Absolute and Relative Risk of Cardiovascular Disease in Men With Prostate Cancer: Results From the Population-Based PCBaSe Sweden.
(
- Contribution to journal › Article
-
Mark
Improving Surveillance and Quality of Life of BRCA Mutation Carriers.
(
- Contribution to journal › Article
-
Mark
Survival and Years of Life Lost in Different Age Cohorts of Patients With Multiple Myeloma.
(
- Contribution to journal › Article
-
Mark
Genomic Changes in Chromosomes 10, 16, and X in Malignant Peripheral Nerve Sheath Tumors Identify a High-Risk Patient Group.
(
- Contribution to journal › Article
-
Mark
Population-Based Study of the Risk of Second Primary Contralateral Breast Cancer Associated With Carrying a Mutation in BRCA1 or BRCA2.
(
- Contribution to journal › Article
-
Mark
Reducing Unnecessary Biopsy During Prostate Cancer Screening Using a Four-Kallikrein Panel: An Independent Replication.
(
- Contribution to journal › Article
-
Mark
Primary Disseminated Multifocal Ewing Sarcoma: Results of the Euro-EWING 99 Trial.
(
- Contribution to journal › Article
-
Mark
Identification of Subtypes in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Reveals a Gene Signature Prognostic of Outcome.
(
- Contribution to journal › Article
- 2009
-
Mark
Updated analysis of a phase II study (20060314) of panitumumab (pmab) with FOLFIRI as first-line treatment of patients (pts) with metastatic colorectal cancer (mCRC)
2009) 45th Annual Meeting of the American-Society-of-Clinical-Oncology In Journal of Clinical Oncology 27(15).(
- Contribution to journal › Published meeting abstract
-
Mark
Outcome in a Prospective Phase II Trial of Medically Inoperable Stage I Non-Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiotherapy.
(
- Contribution to journal › Article
-
Mark
Influence on the Health of the Partner Affected by Tumor Disease in the Wife or Husband Based on a Population-Based Register Study of Cancer in Sweden.
(
- Contribution to journal › Article